Opko Health reported $-26104000 in EBIT for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebit Change
Abbott ABT:US $ 2478M 434M
Acadia Pharmaceuticals ACAD:US $ -33651000 79.36M
Acorda Therapeutics ACOR:US $ -13890000 387K
Agios Pharmaceuticals AGIO:US $ -97640000 3.5M
ALKERMES ALKS:US -34457000 7.87M
Alnylam Pharmaceuticals ALNY:US $ -191686000 44.95M
Amarin AMRN:US -37619000 9.31M
Ardelyx ARDX:US $ -26215000 1.59M
Arrowhead Research ARWR:US $ -72909000 114.46M
Biomarin Pharmaceutical BMRN:US $ 39.15M 9.82M
Bluebird Bio BLUE:US $ -100761000 19.58M
Bristol Myers Squibb BMY:US $ 3197M 9M
Emergent Biosolutions EBS:US $ -72000000 78.4M
Esperion Therapeutics ESPR:US $ -52376000 9.39M
Exact Sciences EXAS:US $ -152993000 23.99M
Exelixis EXEL:US $ 83.71M 463K
Halozyme Therapeutics HALO:US $ 34.06M 41.61M
Insmed INSM:US $ -100938000 513K
Intercept Pharmaceuticals ICPT:US $ -13363000 3.09M
Ironwood Pharmaceuticals IRWD:US $ 55.65M 2.19M
Laboratory Of America LH:US $ 592.3M 109.4M
Lexicon Pharmaceuticals LXRX:US -24007000 627K
Moderna Inc MRNA:US 2.45B 1.78B
Myriad Genetics MYGN:US $ -17800000 2.9M
Neurocrine Biosciences NBIX:US $ 54.7M 51.6M
Opko Health OPK:US $ -26104000 46.32M
Ptc Therapeutics PTCT:US $ -92362000 5.84M
Puma Biotechnology PBYI:US $ 12.06M 12.8M
Quest Diagnostics DGX:US $ 388M 137M
Sarepta Therapeutics SRPT:US $ -211132000 124.25M
Seattle Genetics SGEN:US $ -133111000 61K
Teva Pharmaceutical Industries TEVA:US 734M 55M
Ultragenyx Pharmaceutical RARE:US $ -141593000 4.96M
United Therapeutics UTHR:US $ 201.8M 86.2M